Professor Helena Tomás, senior researcher at the Madeira Chemistry Research Centre (CQM), represented Portugal at the 2nd meeting of the COST Nano2Clinic Management Committee. The European Cooperation in Science and Technology (COST) program finances research and innovation networks, bringing together scientists working in both small and medium-sized enterprises and universities.
The Nano2Clinic network involves 34 European countries and is an important tool for focusing European cancer nanomedicine research efforts. This meeting took place in Riga (Latvia) on October 15th, followed by a scientific network meeting where severals works were presented. CQM participated with the work of the CQM/ARDITI postdoctoral student Mara Gonçalves, whose work dealt with the development of biodegradable nanovoltaic vehicles for anticancer drugs transportation.